Hemics

Eindhoven, Netherlands Founded: 2011 • Age: 15 yrs
Imaging devices for rheumatoid arthritis detection are developed by Hemics.

About Hemics

Hemics is a company based in Eindhoven (Netherlands) founded in 2011. Hemics offers products and services including HandScan. Hemics operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.

  • Headquarter Eindhoven, Netherlands
  • Sectors
    Healthcare
  • Website hemics.com
  • Social LinkedIn X
  • Legal Name Hemics B.V.
Operational Areas
Key Metrics
  • Latest Funding Round
    $55.14K (USD), Grant

    Apr 2015

  • Investors

Products & Services of Hemics

Hemics offers a comprehensive portfolio of products and services, including HandScan.

HandScan
Medical Device

Non-invasive optical tool for assessing RA joint inflammation quickly.

Funding Insights of Hemics

  • Total Rounds 4
  • Last Round Grant β€” $55,142
  • Investors Count 6

All 4 funding rounds of Hemics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2015$55,142Grant––
Jan 2015–Series B–DFZ Participaties, Thuja Capital
–
Nov 2014$62,636Grant––
Sep 2011–Series A––
Valuation history

6 investors in total: 6 institutional.

Investors in Hemics

Hemics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BOM and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
–eicfund.euBrussels, Belgium
-
–dfzparticipaties.nl-
Early-stage centric life sciences focused VC firm funding in Netherlands, Belgium and the US
–thujacapital.comUtrecht, Netherlands
Support is offered for Hudson test preparation in recruitment.
–pointoneinnovationfund.nl-
Investments are directed by BOM toward early and growth-stage firms.
1983bom.nlTilburg, Netherlands
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Hemics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Hemics

3 dated milestones of Hemics across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Hemics is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $55K.

Competitors of Hemics

Hemics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tricemedical.com2012King Of Prussia, United States$85.47M67
Needle-based visualization devices for orthopedic diagnostics are developed.
edgesurgical.com2015Chicago, United States$16.99M–
Digital depth gauges for orthopedic bone measurements are supplied.
orthoscan.com2002Scottsdale, United States$8.33M148
Mini C-arms for orthopedic imaging are developed by OrthoScan.
onicorp.com1997Boston, United States$28M–
MRI systems for extremity imaging are developed and marketed.
bindex.fi2011Kuopio, Finland––
Ultrasound-based POC device for osteoporosis screening is developed.
rossumrobot.cn2017Haidian, China$14.33M–
Robotic surgical systems for orthopedic treatments are provided.
echolightmedical.com2010Lecce, Italy$4.4M–
Radiation-free bone densitometers for osteoporosis assessment are developed.
activelifescientific.com2007Santa Barbara, United States$3.26M6
Bone and tissue quality measurement devices are developed.
genourob.com2007Laval, France$417,81222
Medical devices to measure knee ligament laxity and enhance rehabilitation
Premium access

Detailed competitors of Hemics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Hemics

10 companies that operate in the same segment as Hemics (Orthopedics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Prosthetic and orthotic devices are developed for individuals with disabilities.
1919Duderstadt, Lower Saxony, GermanyUSD 17 MUSD 1.97 B–
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of drugs for treating rare and autoimmune diseases
2008Dublin, IrelandUSD 61.78 MUSD 617.41 M–
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M––
Robotic arms are provided for mobility and rehabilitation support.
2004Boston, Massachusetts, United StatesUSD 17.21 MUSD 40.93 M185
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Exoskeletons for medical rehabilitation and industrial productivity are provided.
2005United StatesUSD 24.37 MUSD 71.6 M61
Stabilization devices for healthcare are manufactured by the company.
2005New York, New York, United StatesUSD 142.15 M–43
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Hemics

Hemics was founded in 2011.

Hemics is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.

Hemics was established in 2011 as a spin-off from Royal Philips Electronics and is based in Eindhoven, Netherlands. The company operates in the medical device sector, where non-invasive optical technology is utilized to produce imaging systems for rheumatoid arthritis. These systems enable fast, operator-independent detection of inflammation, supporting rheumatologists in the objective evaluation of patient inflammatory status for treatment decisions.

Hemics's top competitors include Edge Surgical, Trice Medical and Echolight Medical.

Hemics offers HandScan.

Hemics has 6 investors. Key investors include European Union, BOM, EIC Fund, DFZ Participaties, and Thuja Capital.

Hemics operates through Hemics B.V..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available